Skip to main content
. 2022 Jan 19;58(2):153. doi: 10.3390/medicina58020153

Figure 2.

Figure 2

Kaplan–Meier estimates of progression-free survival (PFS) stratified for the median values of sVCAM-1, sICAM-1, and sTNF-R2 levels. Median values of PFS for higher and lower levels are as follows: 14 (4–44) vs. 5 (5–13); 12 (5-) vs. 5 (3–23); 14 (4–47) vs. 6 (3–13) months. The log-rank test p-value of survival curves comparison were as follows: 0.07, <0.05 and <0.05, respectively.